Marcus Flores, PharmD, BCPS, BCOP, discusses the vital role of pharmacists in multidisciplinary cancer care, exploring ...

Soft tissue sarcomas (STS) are rare malignant tumors arising from connective tissues such as muscle, fat, and blood vessels, ...

Sophia Humphreys, PharmD, MHA, BCBBS, discusses common barriers to cancer therapy and how care teams can assist patients in ...

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

Testosterone therapy lacks evidence for preventing muscle loss, bone fractures, heart disease, or cognitive decline in women.

Panelists discuss how: LDL-C control remains a national crisis, with many patients not on therapy or failing to reach target ...

MBS significantly reduces liver-related complications and other health risks in patients with SLD, including cardiovascular, ...

Up to 4 million people may lose coverage, increasing uninsured rates, especially in non-Medicaid expansion states and among ...

Panelists discuss how schizophrenia’s immense personal and financial burden calls for early, integrated, and sustained care ...

Panelists discuss how schizophrenia presents a wide spectrum of symptoms categorized into positive, negative, and cognitive ...

US-based patients with idiopathic pulmonary fibrosis (IPF) had a slower decline in forced vital capacity (FVC) when they received nerandomilast (Jascayd; Boehringer Ingelheim) compared with placebo, a ...

Lisa Taylor-Swanson, PhD, explains how including Indigenous and Hispanic women in conversations around menopause care helps fine-tune interventions. How do clinicians balance evidence-based practices ...